Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Cancers · 20.10.2024 · 16 (20) · 3542
DOI: 10.3390/cancers16203542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.10.2024. Verfasst von Angela Dalia Ricci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, National Institute of Gastroenterology, IRCCS "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Treatment options for intrahepatic cholangiocarcinoma (iCCA), a highly malignant tumor with poor prognosis, are limited. Recent developments in immunotherapy and immune checkpoint inhibitors (ICIs) have offered new hope for treating iCCA. However, several issues remain, including the identification of reliable biomarkers of response to ICIs and immune-based combinations. Tumor immune microenvironment (TIME) of these hepatobiliary tumors has been evaluated and is under assessment in this setting in order to boost the efficacy of ICIs and to convert these immunologically “cold” tumors to “hot” tumors. Herein, the review TIME of ICCA and its critical function in immunotherapy. Moreover, this paper also discusses potential avenues for future research, including novel targets for immunotherapy and emerging treatment plans aimed to increase the effectiveness of immunotherapy and survival rates for iCCA patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Unit, National Institute of Gastroenterology, IRCCS "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
- S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
- Laboratory of Experimental Oncology, National Institute of Gastroenterology, IRCCS "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
- Osteoncology, Soft Tissue and Bone Sarcomas, Innovative Therapy Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
- Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
- Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
ORCID-Profile: Angela Dalia Ricci, Alessandro Rizzo, Rosalba D'Alessandro, Giorgio Frega, Endrit Shahini, Gianluigi Giannelli
Zitieren
APA
Ricci, A. D., Rizzo, A., Schirizzi, A., D'Alessandro, R., Frega, G., Brandi, G., Shahini, E., Cozzolongo, R., Lotesoriere, C., & Giannelli, G. (2024). Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications. Cancers, 16(20), 3542. https://doi.org/10.3390/cancers16203542
Vancouver
Ricci AD, Rizzo A, Schirizzi A, D'Alessandro R, Frega G, Brandi G, et al. Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications. Cancers. 2024;16(20):3542. doi:10.3390/cancers16203542
BibTeX
@article{Ricci2024,
author = {Ricci, Angela Dalia and Rizzo, Alessandro and Schirizzi, Annalisa and D'Alessandro, Rosalba and Frega, Giorgio and Brandi, Giovanni and Shahini, Endrit and Cozzolongo, Raffaele and Lotesoriere, Claudio and Giannelli, Gianluigi},
title = {Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications},
journal = {Cancers},
year = {2024},
volume = {16},
number = {20},
pages = {3542},
doi = {10.3390/cancers16203542}
}
EUVIMED